RE: Fulmar5 Sep 2023 13:18
Hi Fulmar and Jarv55. Fulmar, great history and really useful. I am not worried about the quality of the asset or the deal… which will surely happen at some point. But I think it’s important to also be aware of the numbers.
As of December 31st 2022, we had cash of £616,000 (we’ll find out in the interims the cash position at the end of H1). Our annual cash-burn seems to be significantly above that number which implies that we may already be very low on cash as we wait for this deal to drop.
When the deal is finalised (hopefully in the next week), “we” get a much-needed payment of USD3.5 million… except who is “we”? The press releases say Anglo pays Arc Minerals, but the JV with Anglo is held through “Unico”, of which we only hold approximately 66%, so likely our share would be USD2.33 million. These funds “…will be applied to costs attributable to the negotiation, implementation and performance of the Joint Venture Agreement, to advance the Company's Botswana exploration assets, to fund activities for new project acquisitions, and for general working capital”. I think it’s fair to assume that if we are already short of cash, most of this will go in legal fees and Rothschild fees and over the next 12 months in directors wages/annual operating costs. In fact I am inclined to believe that the reason the Botswana assay results haven’t yet been released is that we need the Anglo deal to pay for the assays – I can’t see any other justification for not publishing them.
Each subsequent year Anglo make a further payment of USD1m of which our 66% share is USD660,000 (£528,000), so that annual payment is unlikely to cover our annual operating costs, but that in itself is not a problem, because it is still a great deal; if Arc have to return to the market to make the finances add up – I don’t see that as a problem.
So be it, this is the lot of being an investor in an AiM company, and we’ll surely sail through this, but there is another factor which I think it’s worth remembering.
On 16th March 2021, Brian McMaster, Ian Lynch, NvS, Remy and Vass surrendered 75.8 million shares which were exercised at 6.94p per share. The Board decreed that to protect the existing cash resources, the payout of the total consideration of £3.47 million (USD4.33 million) in cash would be over the next three years, i.e. before March 2024 (it was stated that this period was intended to coincide with the expected cashflows from the Cheyeza East plant). That £3.47m has to come from somewhere, so when the SP rises on a deal, my personal opinion is that at some point the directors will plan a capital raise to fund this… just no one should be in any doubt what the money is being utilised for.
Why am still invested in Arc? Because the deal was and is by any standard a very good deal and my trust is now in Anglo to find a Tier One asset … but in the meantime I am expecting to be diluted not for operations, but to pay